Ident. | Authors (with country if any) | Title |
---|
000069 |
Perdita Cheshire [Australie] ; Scott Ayton [Australie] ; Kelly L. Bertram [Australie] ; Helen Ling [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Catriona Mclean [Australie] ; Glenda M. Halliday [Australie] ; Sean S. O'Sullivan [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David I. Finkelstein [Australie] ; Elsdon Storey [Australie] ; David R. Williams [Australie] | Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. |
000E43 |
Will Lee [Australie] ; David R. Williams ; Elsdon Storey | Cognitive testing in the diagnosis of parkinsonian disorders: a critical appraisal of the literature. |
001159 |
Luke A. Massey [Royaume-Uni] ; Caroline Micallef [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Helen Ling [Royaume-Uni] ; David R. Williams [Australie] ; Constantinos Kallis [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Tarek Yousry ; Med Habil [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Hans R. J Ger [Royaume-Uni] | Conventional Magnetic Resonance Imaging in Confirmed Progressive Supranuclear Palsy and Multiple System Atrophy |
001165 |
Will Lee [Australie] ; David R. Williams [Australie] ; Elsdon Storey [Australie] | Cognitive Testing in the Diagnosis of Parkinsonian Disorders: A Critical Appraisal of the Literature |
001332 |
Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | The effect of drug treatment on neurogenesis in Parkinson's disease |
001452 |
Giovanni Fabbrini [Italie] ; Marcello Merello [Argentine] ; Andrew H. Evans [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] | Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case |
001463 |
Francisco Cardoso [Brésil] ; John Hodges [Australie] ; Andrew H. Evans [Australie] ; Tamas Revesz [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] | Postural instability, frontotemporal dementia, and ophthalmoplegia: Clinicopathological case |
001615 |
Tracy Henderson [Australie] ; Nellie Georgiou-Karistianis [Australie] ; Owen White [Australie] ; Lynette Millist [Australie] ; David R. Williams [Australie] ; Andrew Churchyard [Australie] ; Joanne Fielding [Australie] | Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease |
001911 |
David R. Williams [Australie, Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)? |
001C45 |
Laura Silveira-Moriyama [Royaume-Uni] ; Graham Hughes [Royaume-Uni] ; Alistair Church [Royaume-Uni] ; Hilary Ayling [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; Aviva Petrie [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Ann Kingsbury [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Hyposmia in progressive supranuclear palsy |
001F42 |
Laura Silveira-Moriyama [Royaume-Uni] ; Graham Hughes [Royaume-Uni] ; Alistair Church [Royaume-Uni] ; Hilary Ayling [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; Aviva Petrie [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Ann Kingsbury [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Hyposmia in Progressive Supranuclear Palsy |
002016 |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of a color coded probability scale to interpret smell tests in suspected parkinsonism |
002491 |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The Use of a Color Coded Probability Scale to Interpret Smell Tests in Suspected Parkinsonism |
002667 |
David R. Williams [Australie] ; Max Cowey [Australie] ; Kate Tuck [Australie] ; Bruce Day [Australie] | Psychogenic propriospinal myoclonus |
002731 |
Sean S. O'Sullivan [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; David A. Gallagher [Royaume-Uni] ; Luke A. Massey [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study |
002C37 |
David R. Williams [Australie, Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Kate Strand [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy |
003B77 |
David R. Williams [Australie] | Psychogenic palatal tremor |
003D05 |
David R. Williams [Australie] | Gaze‐evoked brainstem myoclonus |